Home » Topics » BioWorld Science

BioWorld Science
RSS

Ustekinumab biosimilar DMB-3115 begins phase I trial

Dec. 16, 2019

Funding supports Synedgen's optimization of therapies to restore GI integrity in IBD

Dec. 16, 2019

MHRA clears initiation of phase I trial of brilacidin delayed-release tablets

Dec. 16, 2019

LUSTER-1 and -2 results do not support further development of fevipiprant in asthma

Dec. 16, 2019

FDA approves Vascepa to reduce cardiovascular risk in adults with elevated triglyceride levels

Dec. 16, 2019

Chitotriosidase-1 levels rise prior to onset of ALS symptoms

Dec. 16, 2019

New PI3Kgamma/PI3Kdelta inhibitors synthesized at Incyte

Dec. 16, 2019

Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine patent estrogen receptor antagonists

Dec. 16, 2019

New AXL/c-Met inhibitors disclosed by Shanghai Institute of Materia Medica

Dec. 16, 2019

Decoding EGFR's skin toxicity

Dec. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...